| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |